AllianceBernstein
ALLO icon

AllianceBernstein’s Allogene Therapeutics ALLO Stock Holding History

AllianceBernstein’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$551K Buy
225,878
+18,360
+9% +$40.3K ﹤0.01% 2653
2026
Q1 		$284K Sell
207,518
-88,980
-30% -$178K ﹤0.01% 2909
2025
Q4 		$406K Hold
296,498
– – ﹤0.01% 2763
2025
Q3 		$368K Hold
296,498
– – ﹤0.01% 2848
2025
Q2 		$335K Buy
296,498
+108,090
+57% +$144K ﹤0.01% 2862
2025
Q1 		$275K Sell
188,408
-21,670
-10% -$40.9K ﹤0.01% 2818
2024
Q4 		$447K Hold
210,078
– – ﹤0.01% 2688
2024
Q3 		$588K Hold
210,078
– – ﹤0.01% 2582
2024
Q2 		$489K Buy
210,078
+55,270
+36% +$163K ﹤0.01% 2682
2024
Q1 		$692K Hold
154,808
– – ﹤0.01% 2441
2023
Q4 		$497K Buy
154,808
+10,090
+7% +$28.6K ﹤0.01% 2612
2023
Q3 		$459K Sell
144,718
-18,630
-11% -$81.6K ﹤0.01% 2614
2023
Q2 		$812K Buy
163,348
+62,440
+62% +$338K ﹤0.01% 2387
2023
Q1 		$498K Buy
100,908
+14,800
+17% +$94.9K ﹤0.01% 2578
2022
Q4 		$542K Sell
86,108
-411
-0.5% -$3.81K ﹤0.01% 2587
2022
Q3 		$934K Sell
86,519
-542,988
-86% -$7.38M ﹤0.01% 2321
2022
Q2 		$7.18M Buy
629,507
+538,699
+593% +$4.78M ﹤0.01% 1277
2022
Q1 		$827K Buy
90,808
+100
+0.1% +$1.04K ﹤0.01% 2490
2021
Q4 		$1.35M Sell
90,708
-3,126,577
-97% -$55.2M ﹤0.01% 2351
2021
Q3 		$82.7M Buy
3,217,285
+50,655
+2% +$1.2M 0.03% 481
2021
Q2 		$82.6M Buy
3,166,630
+625,071
+25% +$17.8M 0.03% 486
2021
Q1 		$89.7M Sell
2,541,559
-47,299
-2% -$1.6M 0.04% 435
2020
Q4 		$65.3M Buy
2,588,858
+654,713
+34% +$21.3M 0.03% 499
2020
Q3 		$72.9M Buy
1,934,145
+231,025
+14% +$8.71M 0.04% 428
2020
Q2 		$72.9M Sell
1,703,120
-273,604
-14% -$9.89M 0.04% 418
2020
Q1 		$38.4M Buy
1,976,724
+200,421
+11% +$4.77M 0.03% 518
2019
Q4 		$46.1M Buy
1,776,303
+162,594
+10% +$4.48M 0.03% 566
2019
Q3 		$44M Buy
1,613,709
+84,060
+5% +$2.39M 0.03% 563
2019
Q2 		$41.1M Buy
1,529,649
+164,642
+12% +$4.59M 0.03% 595
2019
Q1 		$39.5M Buy
1,365,007
+79,580
+6% +$2.31M 0.03% 596
2018
Q4 		$34.6M Buy
+1,285,427
New +$34.2M 0.03% 592

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

AllianceBernstein's ALLO Position: Q2 2026 in Review

AllianceBernstein increased its Allogene Therapeutics (ALLO) stake by 8.8% in Q2 2026, buying an estimated $40.3K and bringing the position to 225,878 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

AllianceBernstein first reported a position in ALLO in Q4 2018 and has held it in 31 quarters since. The position peaked at $89.7M in Q1 2021. 210 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • AllianceBernstein held 225,878 shares of Allogene Therapeutics worth $551K as of Q2 2026.
  • AllianceBernstein bought 18,360 Allogene Therapeutics shares in Q2 2026, an estimated $40.3K.
  • Allogene Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2653 holding.
  • AllianceBernstein first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 31 quarters since.
  • AllianceBernstein's Allogene Therapeutics position peaked at $89.7M in Q1 2021.
  • 210 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.